Marsland Alexander M
Department of Dermatology, University of Manchester School of Medicine, Hope Hospital, Stott Lane, Salford, Manchester M6 8HD, UK.
Curr Allergy Asthma Rep. 2006 Jul;6(4):265-9. doi: 10.1007/s11882-006-0058-8.
Chronic urticaria is a debilitating skin disease that is believed to have an underlying autoimmune etiology in 35% to 50% of cases. Patients with autoimmune urticaria have functional antibodies in their sera that release histamine from basophils and mast cells. The C5a component of complement is required for mast cell degranulation in this process and at least augments basophil histamine release. In this article, the evidence that is key to our understanding of autoimmunity and complement in the pathogenesis of a subset of patients with chronic urticaria is outlined. Some of the issues in testing for and treating autoimmune urticaria are discussed.
慢性荨麻疹是一种使人虚弱的皮肤病,据信在35%至50%的病例中存在潜在的自身免疫病因。自身免疫性荨麻疹患者的血清中存在功能性抗体,可从嗜碱性粒细胞和肥大细胞释放组胺。补体的C5a成分在此过程中是肥大细胞脱颗粒所必需的,并且至少会增强嗜碱性粒细胞组胺的释放。本文概述了有助于我们理解慢性荨麻疹患者亚群发病机制中自身免疫和补体的关键证据。还讨论了自身免疫性荨麻疹检测和治疗中的一些问题。